4.4 Review

Role of Nuclear Factor Erythroid 2-Related Factor 2 in Diabetic Nephropathy

Journal

JOURNAL OF DIABETES RESEARCH
Volume 2017, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2017/3797802

Keywords

-

Funding

  1. National Natural Science Foundation of China [81200525]
  2. Jilin Province Science and Technology Development Program [20150520034JH, 20160414014GH]
  3. Jilin Province Scientific Research Program [2016446]
  4. Norman Bethune Program of Jilin University [2015214]

Ask authors/readers for more resources

Copyright (C) 2017 Wenpeng Cui et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Diabetic nephropathy (DN) is manifested as increased urinary protein level, decreased glomerular filtration rate, and final renal dysfunction. DN is the leading cause of end-stage renal disease worldwide and causes a huge societal healthcare burden. Since satisfied treatments are still limited, exploring new strategies for the treatment of this disease is urgently needed. Oxidative stress takes part in the initiation and development of DN. In addition, nuclear factor erythroid 2-related factor 2 (Nrf2) plays a key role in the cellular response to oxidative stress. Thus, activation of Nrf2 seems to be a new choice for the treatment of DN. In current review, we discussed and summarized the therapeutic effects of Nrf2 activation on DN from both basic and clinical studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Medicine, Research & Experimental

A minireview: Role of AMP-activated protein kinase (AMPK) signaling in obesity-related renal injury

Zhuo Li, Jia Li, Xiao Miao, Wenpeng Cui, Lining Miao, Lu Cai

Summary: AMP-activated protein kinase (AMPK) plays a crucial role in obesity-related renal injury, exerting renal protection by modulating lipid metabolism, autophagy, oxidative stress, and other pathways. Further investigation is needed to explore the mechanisms of AMPK in renal diseases.

LIFE SCIENCES (2021)

Article Medicine, Research & Experimental

Detection of microRNA-33a-5p in serum, urine and renal tissue of patients with IgA nephropathy

Lihua Liu, Aosong Duan, Qiaoyan Guo, Guangdong Sun, Wenpeng Cui, Xuehong Lu, Hongyu Yu, Ping Luo

Summary: The study found that the levels of miR-33a-5p in the serum, urine, and kidney tissues of IgA nephropathy (IgAN) patients were significantly lower compared to healthy individuals. Furthermore, the levels of miR-33a-5p decreased with the severity of renal injury and the progression of renal failure in IgAN patients. This suggests that miR-33a-5p detected in the serum and urine could serve as a non-invasive biomarker to reflect the progression of renal injury and renal failure in IgAN patients.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)

Article Hematology

Influence of Early-Onset Peritonitis on Mortality and Clinical Outcomes in ESRD Patients with Diabetes Mellitus on Peritoneal Dialysis: A Retrospective Multicenter Study

Qiaoyan Guo, Yangyang Chen, Liming Yang, Xueyan Zhu, Xiaoxuan Zhang, Qiao Zhao, Xiaohua Zhuang, Yanfeng Wu, Ping Luo, Wenpeng Cui

Summary: The occurrence of early-onset peritonitis (EOP) is significantly associated with lower rates of PDAP-related death and poorer clinical outcomes in patients with diabetes undergoing PD.

BLOOD PURIFICATION (2022)

Article Biochemistry & Molecular Biology

Effect of Fc-Elabela-21 on renal ischemia/reperfusion injury in mice: Mediation of anti-apoptotic effect via Akt phosphorylation

Feng Xu, Man Wu, Xuehong Lu, Hong Zhang, Lin Shi, Yue Xi, Huifen Zhou, Junhong Wang, Lining Miao, Da-Wei Gong, Wenpeng Cui

Summary: The study found that ELA treatment can reduce tissue damage, ROS production, and apoptosis caused by renal ischemia/reperfusion injury. ELA can also inhibit cell apoptosis and restore cell proliferation induced by IRI.

PEPTIDES (2022)

Article Hematology

Risk factors for early death in urgent-start peritoneal dialysis patients: A multicenter retrospective cohort study

Lingfei Meng, Liming Yang, Xueyan Zhu, Zhanshan Sun, Xiaoxuan Zhang, Xinyang Li, Siyu Cheng, Shizheng Guo, Xiaohua Zhuang, Hongbin Zou, Ping Luo, Wenpeng Cui

Summary: Older age, hypoproteinemia, hyperglycemia, higher eGFR, and severe heart failure were independent predicting factors for early death in patients who underwent urgent-start peritoneal dialysis (USPD).

THERAPEUTIC APHERESIS AND DIALYSIS (2022)

Article Hematology

Poorer clinical outcomes of early-onset peritonitis in elderly peritoneal dialysis patients: A longitudinal and multicenter study

Qiaoyan Guo, Yangyang Chen, Ren Wu, Liming Yang, Xueyan Zhu, Qiao Zhao, Xiaohua Zhuang, Yanfeng Wu, Ping Luo, Wenpeng Cui

Summary: Early-onset peritonitis in elderly PD patients is significantly associated with poorer clinical outcomes, including multiple episodes of PD-associated peritonitis (PDAP), technique failure, and all-cause death.

THERAPEUTIC APHERESIS AND DIALYSIS (2022)

Review Pharmacology & Pharmacy

Mini-Review: GSDME-Mediated Pyroptosis in Diabetic Nephropathy

Wen Li, Jing Sun, Xiaoxi Zhou, Yue Lu, Wenpeng Cui, Lining Miao

Summary: Pyroptosis is a lytic programmed cell death that plays a crucial role in diabetic complications. Research has identified various signaling pathways associated with pyroptosis, and explored the potential value of pyroptosis inhibitors in the treatment of diabetic nephropathy.

FRONTIERS IN PHARMACOLOGY (2021)

Article Urology & Nephrology

Risk factors for hypocalcemia in dialysis patients with refractory secondary hyperparathyroidism after parathyroidectomy: a meta-analysis

Dan Gao, Yan Lou, Yingchun Cui, Shengmao Liu, Wenpeng Cui, Guangdong Sun

Summary: According to the current evidence, preoperative serum calcium, preoperative ALP, and preoperative iPTH were significant predictors of hypocalcemia in patients with SHPT after PTX. More attention should be given to patients with these risk factors for the prevention of postoperative hypocalcemia.

RENAL FAILURE (2022)

Article Urology & Nephrology

Feasibility of a break-in period of less than 24 hours for urgent start peritoneal dialysis: a multicenter study

Xi Wen, Liming Yang, Zhanshan Sun, Xiaoxuan Zhang, Xueyan Zhu, Wenhua Zhou, Xiaoqing Hu, Shichen Liu, Ping Luo, Wenpeng Cui

Summary: The study aimed to investigate the safety of initiating peritoneal dialysis (PD) within 24 hours. The results showed that initiating PD within 24 hours of catheter insertion was not associated with increased mechanical complications, infectious complications, or technique failures.

RENAL FAILURE (2022)

Article Hematology

Patients with end-stage renal disease and diabetes had similar survival rates whether they received hemodialysis or peritoneal dialysis

Feng Xu, Yue Yang, Man Wu, Wenhua Zhou, Dongxue Wang, Wenpeng Cui

Summary: Chinese patients with diabetes and end-stage renal disease have similar survival rates whether they undergo hemodialysis or peritoneal dialysis. The choice of dialysis modality should be individualized based on patients' physical condition and local practices.

THERAPEUTIC APHERESIS AND DIALYSIS (2023)

Article Endocrinology & Metabolism

Risk factors for mortality within 6 mo in patients with diabetes undergoing urgent-start peritoneal dialysis: A multicenter retrospective cohort study

Si-Yu Cheng, Li-Ming Yang, Zhan-Shan Sun, Xiao-Xuan Zhang, Xue-Yan Zhu, Ling-Fei Meng, Shi-Zheng Guo, Xiao-Hua Zhuang, Ping Luo, Wen-Peng Cui

Summary: This retrospective cohort study aimed to identify risk factors for mortality during high-risk periods in patients with diabetes undergoing urgent-start peritoneal dialysis (USPD). The results showed that cardiovascular disease was the leading cause of mortality within 6 months and after 6 months. Patients with more obvious baseline heart failure symptoms had a higher risk of mortality both within the first 6 months and after. Independent risk factors for mortality within the first 6 months were advanced age, lower baseline serum creatinine level, higher baseline serum phosphorus level, and baseline NYHA class III-IV. Independent risk factors for mortality after 6 months were advanced age and baseline NYHA class III-IV.

WORLD JOURNAL OF DIABETES (2022)

Article Hematology

Safety of a 24-h-or-less break-in period in elderly patients undergoing urgent-start peritoneal dialysis: A multicenter retrospective cohort study

Siyu Cheng, Liming Yang, Zhanshan Sun, Xiaoxuan Zhang, Xueyan Zhu, Lingfei Meng, Shizheng Guo, Xiaohua Zhuang, Ping Luo, Wenpeng Cui

Summary: This study suggests that initiating peritoneal dialysis within 24 hours after catheter insertion is feasible in elderly patients with ESRD, and the break-in period does not increase the risk of complications.

THERAPEUTIC APHERESIS AND DIALYSIS (2023)

Article Pharmacology & Pharmacy

Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis

Shunyun Xie, Feng Xu, Yue Lu, Yixian Zhang, Xinyang Li, Mengyuan Yu, Wenpeng Cui

Summary: Peritoneal fibrosis is a common complication in patients receiving peritoneal dialysis, and effective treatment is currently unavailable. ELA and APLN have potential therapeutic effects on PD-related fibrosis. ELA-32 can interfere with the EMT of HPMCs by inhibiting the activation of the TGF-beta 1/SMAD2/3, ERK1/2, and AKT pathways.

FRONTIERS IN PHARMACOLOGY (2022)

Review Urology & Nephrology

Impact of peritoneal dialysis modality on patient and PD survival: A systematic review

Pei-Ting Luo, Wei Li, Xin-Yang Li, Yu Zhang, Bing Du, Wen-Peng Cui

Summary: This study conducted a systematic review and meta-analysis to determine the impact of peritoneal dialysis (PD) modality, specifically automated peritoneal dialysis (APD) and continuous ambulatory peritoneal dialysis (CAPD), on all-cause mortality and PD failure. The findings indicate that APD significantly reduces the risk of all-cause mortality compared to CAPD. However, APD and CAPD have similar effectiveness in terms of PD survival. These results support the increased utilization of APD globally, particularly in developing nations where reimbursement for care has been a barrier.

PERITONEAL DIALYSIS INTERNATIONAL (2023)

Article Hematology

Clinical features and risk factors of catheter removal among 1062 episodes of peritoneal dialysis-associated peritonitis: A multicenter 7-year study

Shichen Liu, Liming Yang, Xueyan Zhu, Xiaoxuan Zhang, Lingfei Meng, Xinyang Li, Jing Zhao, Xiaohua Zhuang, Wenpeng Cui

Summary: This study found that the duration of peritoneal dialysis, previous episodes of peritonitis, high dialysate white cell count, Pseudomonas aeruginosa, and polymicrobial infections were all associated with catheter removal. The prevalence of polymicrobial peritonitis and fungal peritonitis has increased.

THERAPEUTIC APHERESIS AND DIALYSIS (2023)

No Data Available